CD2BP2 and breast carcinoma: Cellular experiments revealed that overexpression of CDK1 substantially reversed the proliferation inhibition observed upon CD2BP2‐DT knockdown in breast cancer cells (Figure 7D,E; Figure S6B,C, Supporting Information).